Pfizer COVID-19 pill reduces risk of hospitalization, death by 89 percent, study shows

Pfizer announced Tuesday that a study found that its oral, antiviral COVID-19 pill Paxlovid reduced the risk of hospitalization or death by 89 percent in high-risk patients.Pfizer said that the 2,246 patients in the study were given the…